Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication: potential role for interleukin-6

Authors: Lee T.-M.; Su S.-F.; Hwang J.-J.; Tseng C.-D.; Chen M.-F.; Lee Y.-T.; Wang S.-S.1

Source: Atherosclerosis, Volume 158, Number 2, October 2001 , pp. 471-476(6)

Publisher: Elsevier

Keywords: Cilostazol; Interleukin-6; Intermittent claudication; Lipid; Pentoxifylline; Peripheral vascular disease; Phosphodiesterase inhibitor

Language: English

Document Type: Research article

DOI: 10.1016/S0021-9150(01)00457-9

Affiliations: 1: cDepartment of Surgery, Cardiology Section, National Taiwan University Hospital, , Taipei, Taiwan

Links for this article